<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37201115</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Metagenomic sequencing, molecular characterization, and Bayesian phylogenetics of imported type 2 vaccine-derived poliovirus, Spain, 2021.</ArticleTitle><Pagination><StartPage>1168355</StartPage><MedlinePgn>1168355</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1168355</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2023.1168355</ELocationID><Abstract><AbstractText Label="INTRODUCTION">In 2021, a type 2 vaccine-derived poliovirus (VDPV2) was isolated from the stool of a patient with acute flaccid paralysis (AFP) admitted to Spain from Senegal. A virological investigation was conducted to characterize and trace the origin of VDPV2.</AbstractText><AbstractText Label="METHODS">We used an unbiased metagenomic approach for the whole-genome sequencing of VDPV2 from the stool (pre-treated with chloroform) and from the poliovirus-positive supernatant. Phylogenetic analyses and molecular epidemiological analyses relying on the Bayesian Markov Chain Monte Carlo methodology were used to determine the geographical origin and estimate the date of the initiating dose of the oral poliovirus vaccine for the imported VDPV2.</AbstractText><AbstractText Label="RESULTS">We obtained a high percentage of viral reads per total reads mapped to the poliovirus genome (69.5% for pre-treated stool and 75.8% for isolate) with a great depth of sequencing coverage (5,931 and 11,581, respectively) and complete genome coverage (100%). The two key attenuating mutations in the Sabin 2 strain had reverted (A481G in the 5'UTR and Ile143Thr in VP1). In addition, the genome had a recombinant structure between type-2 poliovirus and an unidentified non-polio enterovirus-C (NPEV-C) strain with a crossover point in the protease-2A genomic region. VP1 phylogenetic analysis revealed that this strain is closely related to VDPV2 strains circulating in Senegal in 2021. According to Bayesian phylogenetics, the most recent common ancestor of the imported VDPV2 could date back 2.6 years (95% HPD: 1.7-3.7) in Senegal. We suggest that all VDPV2s circulating in 2020-21 in Senegal, Guinea, Gambia, and Mauritania have an ancestral origin in Senegal estimated around 2015. All 50 stool samples from healthy case contacts collected in Spain (n = 25) and Senegal (n = 25) and four wastewater samples collected in Spain were poliovirus negative.</AbstractText><AbstractText Label="DISCUSSION">By using a whole-genome sequencing protocol with unbiased metagenomics from the clinical sample and viral isolate with high sequence coverage, efficiency, and throughput, we confirmed the classification of VDPV as a circulating type. The close genomic linkage with strains from Senegal was consistent with their classification as imported. Given the scarce number of complete genome sequences for NPEV-C in public databases, this protocol could help expand poliovirus and NPEV-C sequencing capacity worldwide.</AbstractText><CopyrightInformation>Copyright © 2023 Fernandez-Garcia, Faye, Diez-Fuertes, Moreno-Docón, Chirlaque-López, Faye and Cabrerizo.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fernandez-Garcia</LastName><ForeName>Maria Dolores</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Enterovirus and Viral Gastroenteritis Unit/National Polio Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faye</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diez-Fuertes</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>AIDS Immunopathogenesis Unit, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium of Infectious Diseases, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Docón</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Microbiology Department, Hospital U. Virgen de la Arrixaca, Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, Murcia University, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chirlaque-López</LastName><ForeName>Maria Dolores</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Consortium of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca, Murcia University, Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faye</LastName><ForeName>Ousmane</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Virology Department, Institut Pasteur de Dakar, Dakar, Senegal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrerizo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Enterovirus and Viral Gastroenteritis Unit/National Polio Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bayesian phylogenetic analysis</Keyword><Keyword MajorTopicYN="N">OPV (oral polio vaccine)</Keyword><Keyword MajorTopicYN="N">metagenomics</Keyword><Keyword MajorTopicYN="N">molecular epidemiology</Keyword><Keyword MajorTopicYN="N">recombination</Keyword><Keyword MajorTopicYN="N">vaccine-derived polio virus</Keyword><Keyword MajorTopicYN="N">whole-genome</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>16</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37201115</ArticleId><ArticleId IdType="pmc">PMC10185892</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2023.1168355</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adu F., Iber J., Bukbuk D., Gumede N., Yang S. J., Jorba J., et al. . (2007). Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. Virus Res. 127 (1), 17–25. doi: 10.1016/j.virusres.2007.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2007.03.009</ArticleId><ArticleId IdType="pubmed">17449127</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman M. M., Jorba J., Henderson E., Diop O. M., Shaukat S., Traoré M. A., et al. . (2021). Update on vaccine-derived poliovirus outbreaks — worldwide, January 2020–June 2021. MMWR morbidity and mortality weekly report (USA: Centers for Disease Control and Prevention; ).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8659190</ArticleId><ArticleId IdType="pubmed">34882653</ArticleId></ArticleIdList></Reference><Reference><Citation>Avellón A., Cabrerizo M., De Miguel T., Pérez-Breña P., Tenorio A., Pérez J. L., et al. . (2008). Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain. Emerg Infect. Dis 14 (11), 1807–1809. doi: 10.3201/eid1411.080517</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1411.080517</ArticleId><ArticleId IdType="pmc">PMC2630745</ArticleId><ArticleId IdType="pubmed">18976579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessaud M., Joffret M.-L., Blondel B., Delpeyroux F., Paul A. V., Wimmer E., et al. . (2016). Exchanges of genomic domains between poliovirus and other cocirculating species c enteroviruses reveal a high degree of plasticity. Sci. Rep. 6 (November), 38831. doi: 10.1038/srep38831</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep38831</ArticleId><ArticleId IdType="pmc">PMC5153852</ArticleId><ArticleId IdType="pubmed">27958320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrerizo M., Calvo C., Rabella N., Muñoz-Almagro C., del Amo E., Pérez-Ruiz M., et al. . (2014). Design and validation of a real-time RT-PCR for the simultaneous detection of enteroviruses and parechoviruses in clinical samples. J. Virol Methods 208, 125–128. doi: 10.1016/j.jviromet.2014.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2014.08.008</ArticleId><ArticleId IdType="pubmed">25152526</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrerizo M., Echevarria J. E., Gonzalez I., de Miguel T., Trallero G. (2008). Molecular epidemiological study of HEV-b enteroviruses involved in the increase in meningitis cases occurred in Spain during 2006. J. Med. Virol. 80 (6), 1018–1024. doi: 10.1002/jmv.21197</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21197</ArticleId><ArticleId IdType="pubmed">18428125</ArticleId></ArticleIdList></Reference><Reference><Citation>
Classification and reporting of vaccine-derived polioviruses (VDPV)  (2016). Global polio eradication initiative guidelines (Geneva, Switzerland: WHO; ). Available at: http://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs.</Citation></Reference><Reference><Citation>Combelas N., Holmblat B., Joffret M. L., Colbère-Garapin F., Delpeyroux F. (2011). Recombination between poliovirus and coxsackie a viruses of species c: a model of viral genetic plasticity and emergence. Viruses 3 (8), 1460–1484. doi: 10.3390/v3081460</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3081460</ArticleId><ArticleId IdType="pmc">PMC3185806</ArticleId><ArticleId IdType="pubmed">21994791</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond A. J., Rambaut A., Shapiro B., Pybus O. G. (2005). Bayesian Coalescent inference of past population dynamics from molecular sequences. Mol. Biol. Evol 22 (5), 1185–1192. doi: 10.1093/molbev/msi103</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msi103</ArticleId><ArticleId IdType="pubmed">15703244</ArticleId></ArticleIdList></Reference><Reference><Citation>Faleye T. O. C., Adewumi O. M., Olayinka O. T., Adeniji J. A. (2019). Genomic characterization of a coxsackievirus A20 strain recovered from a child with acute flaccid paralysis in Nigeria. Microbiol. Resource Announcements 8 (42). doi: 10.1128/MRA.00849-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MRA.00849-19</ArticleId><ArticleId IdType="pmc">PMC6797526</ArticleId><ArticleId IdType="pubmed">31624161</ArticleId></ArticleIdList></Reference><Reference><Citation>Faye. M., Kébé O., Diop B., Ndiaye N., Dosseh A., Sam A., et al. . (2022). Importation and circulation of vaccine-derived poliovirus serotype 2, Senegal, 2020-2021. Emerg. Infect. Dis. 28 (10), 2027–2034. doi: 10.3201/eid2810.220847</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2810.220847</ArticleId><ArticleId IdType="pmc">PMC9514370</ArticleId><ArticleId IdType="pubmed">36148906</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerloff N., Sun H., Mandelbaum M., Maher C., Nix W. A., Zaidi S., et al. . (2018). Diagnostic assay development for poliovirus eradication. J. Clin. Microbiol 56 (2). doi: 10.1128/JCM.01624-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01624-17</ArticleId><ArticleId IdType="pmc">PMC5786708</ArticleId><ArticleId IdType="pubmed">29212703</ArticleId></ArticleIdList></Reference><Reference><Citation>
Global Polio Eradication Initiative . Available at: https://polioeradication.org/.</Citation></Reference><Reference><Citation>
Informe anual  (2019) Vigilancia de la parálisis flácida aguda y vigilancia de enterovirus en españa. Available at: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents (Accessed 31 Jan 2023).</Citation></Reference><Reference><Citation>Jegouic S., Joffret M. L., Blanchard C., Riquet F. B., Perret C., Pelletier I., et al. . (2009). Recombination between polioviruses and co-circulating coxsackie a viruses: role in the emergence of pathogenic vaccine-derived polioviruses. PloS Pathog. 5 (5), e1000412. doi: 10.1371/journal.ppat.1000412</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000412</ArticleId><ArticleId IdType="pmc">PMC2669712</ArticleId><ArticleId IdType="pubmed">19412342</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffret M. L., Doté J. W., Gumede N., Vignuzzi M., Bessaud M., Gouandjika-Vasilache I. (2021). Vaccine-derived polioviruses, central African republic, 2019. Emerg Infect. Dis 27 (2), 620–623. doi: 10.3201/eid2702.203173</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2702.203173</ArticleId><ArticleId IdType="pmc">PMC7853572</ArticleId><ArticleId IdType="pubmed">33496226</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew O. M., Sutter R. W., De Gourville E. M., Dowdle W. R., Pallansch M. A. (2005). Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol 59, 587–635. doi: 10.1146/annurev.micro.58.030603.123625</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.58.030603.123625</ArticleId><ArticleId IdType="pubmed">16153180</ArticleId></ArticleIdList></Reference><Reference><Citation>López M. D. C., Cabrerizo M., Herrador B. R. G., Masa-Calles J., Alarcón-Linares M. E., Allende A., et al. . (2021). An imported case of vaccine-derived poliovirus type 2, Spain in the context of the ongoing polio public health emergency of international concern, September 2021. Eurosurveillance 26 (50), 2101068. doi: 10.2807/1560-7917.ES.2021.26.50.2101068</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.50.2101068</ArticleId><ArticleId IdType="pmc">PMC8728495</ArticleId><ArticleId IdType="pubmed">34915974</ArticleId></ArticleIdList></Reference><Reference><Citation>Masa-Calles J., Torner N., López-Perea N., de Mier M de V. T., Fernández-Martínez B., Cabrerizo M., et al. . (2018). Acute flaccid paralysis (AFP) surveillance: challenges and opportunities from 18 years’ experience, Spain, 1998 to 2015. Eurosurveillance 23 (47), 1700423. doi: 10.2807/1560-7917.ES.2018.23.47.1700423</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.47.1700423</ArticleId><ArticleId IdType="pmc">PMC6341937</ArticleId><ArticleId IdType="pubmed">30482263</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ministerio de Sanidad, Asuntos Sociales e Igualdad  (2016) Plan de acción en españa para la erradicación de la poliomielitis [Spanish polio eradication strategy]. Available at: https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunacione.</Citation></Reference><Reference><Citation>
Ministry of Health, Social Services and Equality  (2023) Coberturas de vacunación. datos estadísticos. [Vaccine coverage. statistical data] (Madrid: ). Available at: https://pestadistico.inteligenciadegestion.sanidad.gob.es/publico (Accessed 31 Jan 2023).</Citation></Reference><Reference><Citation>Montmayeur A. M., Ng T. F., Schmidt A., Zhao K., Magana L., Iber J., et al. . (2017). High-throughput next-generation sequencing of polioviruses. J. Clin. Microbiol. 55 (2), 606–615. doi: 10.1128/JCM.02121-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02121-16</ArticleId><ArticleId IdType="pmc">PMC5277531</ArticleId><ArticleId IdType="pubmed">27927929</ArticleId></ArticleIdList></Reference><Reference><Citation>Muslin C., Mac Kain A., Bessaud M., Blondel B., Delpeyroux F. (2019). Recombination in enteroviruses, a multi-step modular evolutionary process. Viruses 11 (9), E859. doi: 10.3390/v11090859</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11090859</ArticleId><ArticleId IdType="pmc">PMC6784155</ArticleId><ArticleId IdType="pubmed">31540135</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H., Varona S., Monzón S., Espinosa-Carrasco J., Heuer M. L., Underwood A., et al. . Nf-core/viralrecon: nf-core/viralrecon v2.4.1 - plastered magnesium marmoset.</Citation></Reference><Reference><Citation>Rakoto-Andrianarivelo M., Guillot S., Iber J., Balanant J., Blondel B., Riquet F., et al. . (2007). Co-Circulation and evolution of polioviruses and species c enteroviruses in a district of Madagascar. PloS Pathog. 3 (12), e191. doi: 10.1371/journal.ppat.0030191</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0030191</ArticleId><ArticleId IdType="pmc">PMC2134956</ArticleId><ArticleId IdType="pubmed">18085822</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A., Drummond A. J., Xie D., Baele G., Suchard M. A. (2018). Posterior summarization in Bayesian phylogenetics using tracer 1.7. Systematic Biol. 67 (5), 901–904. doi: 10.1093/sysbio/syy032</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sysbio/syy032</ArticleId><ArticleId IdType="pmc">PMC6101584</ArticleId><ArticleId IdType="pubmed">29718447</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A., Lam T. T., Carvalho L. M., Pybus O. G. (2016). Exploring the temporal structure of heterochronous sequences using TempEst (formerly path-O-Gen). Virus Evol 67 (5), 901–904. doi: 10.1093/ve/vew007</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vew007</ArticleId><ArticleId IdType="pmc">PMC4989882</ArticleId><ArticleId IdType="pubmed">27774300</ArticleId></ArticleIdList></Reference><Reference><Citation>Randazzo W., Truchado P., Cuevas-Ferrando E., Simón P., Allende A., Sánchez G. (2020). SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area. Water Res 181, 115942. doi: 10.1016/j.watres.2020.115942</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.watres.2020.115942</ArticleId><ArticleId IdType="pmc">PMC7229723</ArticleId><ArticleId IdType="pubmed">32425251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren R. B., Moss E. G., Racaniello V. R. (1991). Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 65 (3), 1377–1382. doi: 10.1128/jvi.65.3.1377-1382.1991</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.65.3.1377-1382.1991</ArticleId><ArticleId IdType="pmc">PMC239915</ArticleId><ArticleId IdType="pubmed">1847458</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro B., Rambaut A., Drummond A. J. (2006). Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol. Biol. Evol 23 (1), 7–9. doi: 10.1093/molbev/msj021</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msj021</ArticleId><ArticleId IdType="pubmed">16177232</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman L. M., Manor Y., Handsher R., Delpeyroux F., McDonough M. J., Halmut T., et al. . (2000). Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J. Clin. Microbiol. 38 (10), 3729–3734. doi: 10.1128/JCM.38.10.3729-3734.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.38.10.3729-3734.2000</ArticleId><ArticleId IdType="pmc">PMC87465</ArticleId><ArticleId IdType="pubmed">11015392</ArticleId></ArticleIdList></Reference><Reference><Citation>
UNICEF Senegal  (2022). Available at: https://www.unicef.org/senegal/en/stories/kicking-polio-out-senegal.</Citation></Reference><Reference><Citation>Wood D. E., Lu J., Langmead B. (2019). Improved metagenomic analysis with kraken 2. Genome Biol 20 (1), 257. doi: 10.1186/s13059-019-1891-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-019-1891-0</ArticleId><ArticleId IdType="pmc">PMC6883579</ArticleId><ArticleId IdType="pubmed">31779668</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization  (2004. a). Polio laboratory manual. 4th edition (Geneva, Switzerland: World Health Organization; ). Available at: http://apps.who.int/iris/bitstream/10665/68762/1/WHO_IVB_04.10.pdf.</Citation></Reference><Reference><Citation>
World Health Organization  (2004. b). An alternative test algorithm for poliovirus isolation and characterization. polio laboratory manual. 4th edition (Geneva: World Health Organization; ). Available at: http://polioeradication.org/wp-content/uploads/2017/05/NewAlgorithmForPoliovirusIsola.</Citation></Reference><Reference><Citation>
World Health Organization  (2021. a). Polio eradication strategy 2022–2026: executive summary (Geneva, Switzerland: World Health Organization; ). Available at: https://apps.who.int/iris/bitstream/handle/10665/341938/9789240024830-eng.pdf.</Citation></Reference><Reference><Citation>
World Health Organization  (2021. b). 35th meeting of the European regional certification commission for poliomyelitis eradication (Geneva, Switzerland: World Health Organization; ). Available at: https://www.who.int/europe/publications/i/item/WHO-EURO-2022-5197-44961-64000.</Citation></Reference><Reference><Citation>
World Health Organization  (2022). Global circulating vaccine-derived poliovirus (cVDPVs) (Geneva, Switzerland: World Health Organization; ). Available at: https://polioeradication.org/wp-content/uploads/2022/12/weekly-polio-analyses-cVDPV-20221220.pdf.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>